期刊文献+

我国药物临床试验机构的地域及专业分布 被引量:7

Regional and Professional Distribution of Clinical Drug Trial Institutions in China
原文传递
导出
摘要 目的:了解我国药物临床试验机构的地域和专业分布状况,为临床试验的实施提供有益的信息。方法:对国家食品药品监督管理总局网站2005-2013年发布的药物临床试验机构认定的公告数据进行整理、分析。结果:截至2013年底,全国共认定403家临床试验机构的2 982个专业科室。从地域看,列临床试验机构数量前10位的省份中,有8个是东部省份,其中以北京、上海、广东等最多;省会城市的临床试验机构数量远高于非省会城市,占全部临床试验机构的80%。从专业看,列专业科室数量前10位的省份中,有7个是东部省份;西医专业科室数量占全部总认定数量的79.3%,中医专业仅占20.7%;心血管、消化、呼吸、肿瘤等专业分别认定252、227、225、213家,居各认定专业的前列。结论:应鼓励医疗机构参与临床试验机构的认定,增加临床试验机构和某些专业科室的认定数量;加强欠发达地区的医疗资源投入,平衡地区差异;出台有关政策引导一些专业的认定数量,做到统筹兼顾,平衡临床试验机构资源。 OBJECTIVE: To study the regional and professional distribution of clinical drug trial institutions in China, and to provide the information to support the conduction of clinical trial. METHODS: The data from the drug clinical trial institution data- base (2005-2013) issued by CFDA website were summarized and analyzed. RESULTS: By the end of 2013, a total of 2 982 professional departments in 403 hospitals were identified as clinical trial institution. Among top 10 institutions, 8 clinical trail institutions located in the eastern region, especially in Beijing, Shanghai and Guangdong province. 80% clinical trial institutions came from the provincial capital cities, which were far more than those of non-provincial capital cities. Among top 10 professional departments, 7 departments came from the eastern regions; western medicine professional departments accounted for 79.3% of the total, while TCM professional accounts for only 20.7%. The professional department in the forefront included 252 cardiovascular departments, 227 digestive departments, 225 respiratory departments, 213 tumor departments, etc. CONCLUSIONS: The related government department should encourage the medical institutions to participate in the identification of clinical drug trial institution so as to increase the number of clinical trial institution and professional departments; enhance the input of medical resource in undeveloped area and balance regional difference; publish related policies to guide the identification of professional institutions so as to give overall consideration and balance medical resource.
出处 《中国药房》 CAS CSCD 2014年第37期3471-3474,共4页 China Pharmacy
关键词 药物临床试验机构 地域分布 专业分布 Clinical drug trial institution Regional distribution Professional distribution
  • 相关文献

参考文献10

二级参考文献25

  • 1孙燕.肿瘤药物治疗百年回顾与展望[J].中华肿瘤杂志,2004,26(11):701-703. 被引量:16
  • 2孙燕.循证医学和临床研究的GCP指导原则[J].循证医学,2005,5(1):39-44. 被引量:2
  • 3袁方.我国开展国际多中心临床试验的现状及改进措施[J].医药导报,2007,26(1):100-102. 被引量:22
  • 4国家食品药品监督管理局.《药物临床试验机构资格认定办法(试行)》,国食药监安[2004]44号[EB/OL].http://www.sda.gov.cn/WS01/CL0058/9346.html,2004-02-19.
  • 5中华人民共和国卫生部.《2010中国卫生统计年鉴》[EB/OL].http://www.moh.gov.cn/publicfiles/business/htmlflles/zwgkzt/ptjnj/year2010/index2010.html,2010-10-08.
  • 6陈贵廷 薛赛琴.最新国外疾病诊断标准[S].北京:学苑出版社,1991.209-211,214-215.
  • 7解琴.我国药物临床试验机构组建的回顾与现状[J].中国临床药理学杂志,2007,23(5):397-400. 被引量:19
  • 8Suvapun Bunniran, David J. MeCaffre) et al. Pharmaceutical product withdrawal: Attributions of blame and its impact on trust. Research in Social and Administrative Pharmacy, 5 (2009): 262- 273.
  • 9lain Chalmers. From oplimism to disillusion about commitmem to transparent> in the medico-industrial complex. J R Soe Med, 206:99:337- 341.
  • 10"Sergio Sismondo, Pharmaceutical company funding and its consequences:A qualitative systematic review. Contemporary Clinical Trials, 29 (2008):10- 113.

共引文献80

同被引文献47

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部